Biomatter Raises $18 Million in Oversubscribed Series A to Expand AI-Powered Enzyme Design and Accelerate Industrial Applications Biomatter, a biotechnology company specializing in custom enzyme design, has announced the successful…
PepGen Announces Pricing of $125 Million Public Offering to Advance Clinical Development of Oligonucleotide Therapies PepGen, a clinical-stage biotechnology company developing innovative oligonucleotide-based medicines for rare genetic diseases, has announced…
FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for Merck’s KEYTRUDA in MSI-H Solid Tumors Promega Corporation has announced that the U.S. Food and Drug Administration (FDA)…
Alpha Cognition Reports Record Third-Quarter 2026 ZUNVEYL Revenue and Expanding Prescriber Adoption, Reaffirms Path to Profitability in 2027 Alpha Cognition Inc., a biopharmaceutical company focused on developing and commercializing novel…
enGene Therapeutics Appoints Erik Goluboff as Chief Medical Officer and Jason Duncan as Chief Legal and Administrative Officer enGene Therapeutics Inc., a clinical-stage biotechnology company focused on developing non-viral genetic…
Delcath Systems to Be Featured on Health Uncensored with Dr. Drew in Segment on Precision Oncology for Metastatic Liver Cancer Delcath Systems, Inc., an interventional oncology company focused on developing…
Teiko Publishes Bioanalysis Review Highlighting Sample Stabilization and Mass Cytometry for Immune Monitoring in Global Oncology Trials Teiko, a CLIA-certified clinical laboratory specializing in immune response monitoring, has announced the…
Hospital for Special Surgery Presents Three Studies Exploring Precision Medicine Approaches to Improve Rheumatoid Arthritis Treatment Hospital for Special Surgery (HSS) researchers have presented findings from three new studies aimed…
Palleon Pharmaceuticals Reports Early Proof-of-Concept Results for HLX79/E-602 in Primary Membranous Nephropathy Palleon Pharmaceuticals, a clinical-stage biotechnology company developing innovative glycan-editing therapeutics for autoimmune diseases and cancer, has announced encouraging…
Mosaic Clinical Technologies Reports AI Vision-Language Models Improve Radiology Detection by Up to 110% Across More Than 237,000 Imaging Exams Mosaic Clinical Technologies, Inc. has announced promising preliminary research findings…
PharmaCyte Biotech Announces 1-for-19 Reverse Stock Split to Regain Nasdaq Listing Compliance PharmaCyte Biotech, Inc., a biotechnology company, has announced that its board of directors has approved a 1-for-19 reverse…
AstraZeneca Awards $1.6 Million in Grants to 55 Nonprofits Through 2026 Community Solutions Challenge to Advance Health Equity AstraZeneca has announced $1.6 million in grant funding for nonprofit organizations across…